Group One Trading’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-30,300
Closed -$32K 8403
2022
Q3
$32K Buy
30,300
+11,900
+65% +$27.1K ﹤0.01% 5770
2022
Q2
$34K Sell
18,400
-40,200
-69% -$97.7K ﹤0.01% 5902
2022
Q1
$209K Sell
58,600
-20,400
-26% -$100K ﹤0.01% 4756
2021
Q4
$680K Buy
79,000
+19,900
+34% +$127K ﹤0.01% 3769
2021
Q3
$449K Buy
59,100
+55,500
+1,542% +$468K ﹤0.01% 4319
2021
Q2
$24K Buy
+3,600
New +$22.7K ﹤0.01% 7093

Other funds holding LHDX

Group One Trading's LHDX Position: Q1 2023 in Review

Group One Trading sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 4,752 shares — an estimated $528 sold.

Group One Trading first reported a position in LHDX in Q2 2021 and held it in 6 quarters. The position peaked at $60K in Q1 2022. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

  • Group One Trading reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Group One Trading sold 4,752 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $528.
  • Group One Trading first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Group One Trading's Lucira Health, Inc. Common Stock position peaked at $60K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.